RSNA 2017 News
By AuntMinnie.com staff writers
November 23, 2017

French contrast developer Guerbet plans to launch a new contrast management software offering called Contrast&Care at the RSNA 2017 conference.

Contrast&Care is an integrated software application that groups data related to contrast exams, such as media type, injection protocol, and patient data, and interfaces with imaging informatics systems like RIS and PACS networks. Information generated by injectors is transmitted to Contrast&Care after each exam, enabling users to view the history of each patient, as well as the exams with contrast that have been performed and the doses of contrast media administered.

Contrast&Care also gives users the option of reviewing and creating libraries for contrast protocols, in addition to viewing statistics and trends related to injection activity and the use of contrast media.

Contrast&Care complements Dose&Care in Guerbet's portfolio of contrast software. The product will begin shipping at the beginning of 2018.

Guerbet posts revenue growth for Q3
Contrast agent manufacturer Guerbet posted revenue increases for the third-quarter and nine-month periods of its fiscal 2017.
Guerbet issues statement on FDA gadolinium vote
Contrast agent manufacturer Guerbet has issued a statement regarding gadolinium retention from MRI contrast media following today's meeting of the U.S....
Guerbet lands expanded FDA clearance for Dotarem
French contrast developer Guerbet said the U.S. Food and Drug Administration (FDA) has approved its Dotarem gadolinium-based MRI contrast agent for use...
Guerbet phases out 2 contrast agents
French contrast developer Guerbet is phasing out worldwide sales of its Optimark (gadoversetamide) MRI contrast agent and Hexabrix (meglumine and sodium...
Guerbet invests in French medical technology fund
French contrast developer Guerbet signed an equity acquisition of 15 million euros ($17 million U.S.) in the BioMedTech fund managed by Truffle Capital,...

Copyright © 2017 AuntMinnie.com

Last Updated np 11/21/2017 5:02:00 PM